Methoxyflavone inhibitors of cytochrome P450

Journal of Chemical Crystallography

Volumn 38, Issue 4, 2008, Pages 231-237

  McKendall, Michael ^a   Smith, Tasha ^a   Anh, Kien ^a   Ellis, Jamie ^a   McGee, Terri ^a   Foroozesh, Maryam ^a   Zhu, Naijue ^a   Stevens, Cheryl L Klein ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

Flavone; P450 inhibitors; X ray crystal structures

Indexed keywords

EID: 40249099408     PISSN: 10741542     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10870-007-9310-x     Document Type: Article

References (32)

1. Guengerich FP (2004) In: Oritz de Montellano PR (ed) Cytochrome P450 structure, mechanism, and biochemistry. Kluwer Academic/Plenum Publisher, New York, pp 377-463
2. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J (1995) Curr Biol 3:41
3. Capdevila JH, Zeldin D, Makita K, Karara A, Falck JR (2004) In: Ortiz de Montellano PR (ed) Cytochrome P450 structure, mechanism, and biochemistry. Kluwer Academic/Plenum Publisher, New York, pp 531-545
4. Raner GM, Vas ADN, Coon MJ (1996) Mol Pharmacol 49:515
5. Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE (2000) Mol Cell 5:121
6. Schenkman JB, Greim H (eds) (1993) Cytochrome P450 handbook of experimental pharmacology, vol 105. Springer-Verlag, Berlin, pp 1-739
7. Guengerich FP, Kim D-H, Iwasaki M (1991) Chem Res Toxicol 4:168
8. Zhang JY, Wang Y, Prakash C (2006) Curr Drug Metab 7(8):939
9. Estabrook RW (1996) FASEB J 10:202
10. Masters BSS (1996) FASEB J 10:205
11. Graham-Lorence S, Peterson JA (1996) FASEB J 10:206
12. Whitlock JP Jr, Okino ST, Dong L, Ko HP, Clarke-Katenberg R, Ma Q, Li H (1996) FASEB J 10:809
13. Gonzales FJ, Lee YH (1996) FASEB J 10:112
14. Johnson EF, Palmer CNA, Griffin KJ, Hsu MH (1996) FASEB J 10:1241
15. Prough RA, Linder MW, Pinaire JA, Xiao GA, Falkner KC (1996) FASEB J 10:1369
16. Park KY, Jung GO, Lee KT, Choi J, Choi MY, Kim GT, Jung HJ, Park HJ (2004) J Ethnopharmacol 90(1):73
17. Uhl M, Ecker S, Kassie F, Lhoste E, Chakraborty A, Mohn G, Knasmueller S (2003) Arch Toxicol 77(8):477
18. Alworth WL, Viaje A, Sandoval A, Warren BS, Slage TJ (1991) Carcinogenesis 12:1209
19. Alworth WL, Young-Sciame Y, Hecht SS (1993) Carcinogenesis 14:1711
20. Christou M, Moore CJ, Gould MN, Jefcoate CR (1987) Carcinogenesis 8:73
21. Ares JJ, Outt PE, Kakodkar SV, Busse RC, Geiger JG (1993) J Org Chem 58:7903
22. Mackay S, Gilmore CJ, Edwards C, Stewart N, Shankland K (1999) MaXus computer program for the solution and refinement of crystal structures. Bruker Nonius, The Netherlands; MacScience: Japan and The University of Glasgow
23. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT (1994) Biochem Pharmacol 48:923
24. Buters JT, Schiller CD, Chou RC (1993) Biochem Pharmacol 46:1577
25. Deluca JG, Dysaft GR, Rasnick D, Bradley MO (1989) Biochem Pharmacol 37:1731
26. Hopkins NE, Foroozesh MK, Alworth WL (1992) Biochem Pharmacol 44:787
27. Bhattacharya KK, Brake PB, Elton SE, Otto SA, Jefcoate CR (1995) J Biol Chem 270:11595
28. Nuwaysir EF, Dragan YP, Jefcoate CR, Jordan VC, Pitot HC (1995) Cancer Res 55:1780
29. Robertson DW, Katzenellenbogen JA, Long DJ, Rorke EA, Katzenellenbogen BS (1982) J Steroid Biochem 16:1
30. Styles JA, Davies A, Lim CK, de Matties F, Stanley LA, White INH, Yuan ZX, Smith LL (1994) Carcinogenesis 15:5
31. Pathak D, Bodell WJ (1994) Carcinogenesis 15:529-532
32. SYBYL Molecular Modeling Software, Version 7.3 (2007) Tripos Associates Inc.; St. Louis, Missouri 63144